Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

COVID-19

Inflammatory macrophages

Nature 606, 585–593 (2022)

High levels of cytokines IL-1β and IL-18 correlate with COVID-19 severity in patients. In Nature, Sefik et al. show that SARS-CoV-2 infection of lung-resident macrophages drives disease pathology. When mice with a humanized immune system (MISTRG6-hACE2) were infected with a tagged (mNG) SARS-CoV-2 strain, lung macrophages were mNG+ and viral subgenomic RNA+, indicating that the virus replicates in these cells. Infection is dependent on ACE2 and antibody-mediated Fc-receptor uptake. ASC formation, as a readout of inflammasome activation, is detected in mNG+ lung macrophages and correlates with serum levels of inflammatory cytokines (IL-18 and IL-1RA) and markers of pyroptosis (GSDMD). Blocking viral entry or replication in lung macrophages reduces expression of IL-18, IL-1RA and CXCL10. NLRP3 inhibitors attenuate the production of IL-18, IL-1RA and GSDMD, reverse lung immune pathology and induce higher viral loads in the lung, which suggests that inflammasome activation restricts viral propagation at the cost of hyperinflammation in the lung.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ioana Visan.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Visan, I. Inflammatory macrophages. Nat Immunol 23, 988 (2022). https://doi.org/10.1038/s41590-022-01261-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41590-022-01261-8

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing